Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s)
- PMID: 8662980
Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s)
Abstract
Steroid and thyroid hormone receptors exhibit striking structural and functional similarity, suggesting that these nuclear receptors may enhance transcription of target genes by similar mechanisms. To address this issue, we studied transcriptional interference between progesterone and thyroid hormone receptors in vivo and in vitro. We observed that transcriptional interference occurred in a ligand-dependent manner between progesterone receptor-B (PR-B) and thyroid hormone receptor (TR) alpha or beta in transient transfection experiments. Ligand-occupied TRalpha or TRbeta, but not the unliganded receptor, strongly suppressed transactivation of a progesterone-responsive reporter gene by endogenous PRs in human breast carcinoma T47D cells. Ligand-dependent inhibitory cross-talk also occurred between transfected PR-B and TRalpha or TRbeta and vice versa in CV1 cells. This phenomenon did not require DNA binding by the "interfering" receptor but required it to be hormone-bound, indicating that a transcriptionally active form of the interfering receptor is essential for the interfering effect. To analyze further the mechanism of the ligand-dependent cross-talk, we reproduced transcriptional interference between PR and TR in a cell-free transcription system. We observed that the addition of triiodothyronine-bound recombinant TRbeta or a ligand binding domain (LBD) peptide(145-456) inhibited specifically transcriptional activation of a progesterone-responsive gene by endogenous PRs in nuclear extracts of T47D cells, while the basal level of transcription from a minimal TATA-promoter or transcription from an adenovirus major-late promoter remained unaffected. These results indicated that a transactivation function within the LBD of the interfering receptor TRbeta was likely to interact with a mediator protein(s), termed coactivator, that is distinct from basal transcription factors and is critical for efficient PR-induced transactivation. This concept was reinforced by biochemical evidence that treatment of T47D extracts with immobilized TRbeta LBD depleted the extract of the coactivator function in a triiodothyronine-dependent manner and markedly impaired progesterone-induced transactivation of progesterone response element-linked genes. Deletion of six amino acids(451-456) in the extreme COOH terminus of TRbeta resulted in a receptor that retained the ability to bind thyroid hormone but failed to inhibit progesterone-dependent transcription. Interestingly, these six amino acids are present in a region that is highly conserved among various nuclear hormone receptors and contains a ligand-dependent transactivation function, AF-2. Based on these results, we propose that a limiting coactivator protein(s) interacts with the AF-2 of PR or TR and mediates transactivation by the ligand-bound receptor. This regulatory molecule(s) may therefore serve as a common functional link between the pathways of hormone-inducible gene activation by various members of the nuclear receptor superfamily.
Similar articles
-
Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.Mol Endocrinol. 1997 Jun;11(6):755-67. doi: 10.1210/mend.11.6.0003. Mol Endocrinol. 1997. PMID: 9171239
-
Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.Mol Cell Biol. 1996 May;16(5):1909-20. doi: 10.1128/MCB.16.5.1909. Mol Cell Biol. 1996. PMID: 8628257 Free PMC article.
-
Interactions of estrogen- and thyroid hormone receptors on a progesterone receptor estrogen response element (ERE) sequence: a comparison with the vitellogenin A2 consensus ERE.Mol Endocrinol. 1997 Oct;11(11):1581-92. doi: 10.1210/mend.11.11.0003. Mol Endocrinol. 1997. PMID: 9328341
-
Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.Recent Prog Horm Res. 1997;52:141-64; discussion 164-5. Recent Prog Horm Res. 1997. PMID: 9238851 Review.
-
Thyroid hormone and thyroid hormone nuclear receptors: History and present state of art.Endocr Regul. 2021 May 21;55(2):103-119. doi: 10.2478/enr-2021-0012. Endocr Regul. 2021. PMID: 34020531 Review.
Cited by
-
Early-onset breast cancer in a woman with Graves' disease.Int J Clin Exp Med. 2012;5(4):358-62. Epub 2012 Aug 22. Int J Clin Exp Med. 2012. PMID: 22993658 Free PMC article.
-
Early-onset breast disease: case of a Grave condition with a favorable prognosis.Int J Clin Exp Med. 2012;5(3):267-70. Epub 2012 Jun 15. Int J Clin Exp Med. 2012. PMID: 22837803 Free PMC article.
-
E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex.Mol Cell Biol. 2000 Mar;20(6):2138-46. doi: 10.1128/MCB.20.6.2138-2146.2000. Mol Cell Biol. 2000. PMID: 10688660 Free PMC article.
-
Molecular Basis of Steroid Action in the Prostate.Cellscience. 2005 Apr 28;1(4):27-55. doi: 10.1901/jaba.2005.1-27. Cellscience. 2005. PMID: 16971966 Free PMC article. No abstract available.
-
Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.Cell Metab. 2006 Oct;4(4):303-11. doi: 10.1016/j.cmet.2006.09.003. Cell Metab. 2006. PMID: 17011503 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials